Pharma Equity Groups datterselskab, Reponex Pharmaceuticals A/S, rapporterer meget positive slutresultater fra det klinisk fase-2 studie med selskabets patenterede lægemiddelkandidat RNX-051.
April 05, 2024 05:22 ET
|
Pharma Equity Group A/S
5. april 2024 Meddelelse nr. 11 Pharma Equity Groups datterselskab, Reponex Pharmaceuticals A/S, rapporterer meget positive slutresultater fra det klinisk fase-2 studie med selskabets patenterede...
Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051.
April 05, 2024 05:22 ET
|
Pharma Equity Group A/S
5 April 2024 Company Announcement No. 11 Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s...
Indkaldelse til ordinær generalforsamling i Pharma Equity Group A/S
March 25, 2024 08:06 ET
|
Pharma Equity Group A/S
25. marts 2024 Meddelelse nr. 10 Indkaldelse til ordinær generalforsamling i Pharma Equity Group A/S Bestyrelsen indkalder hermed til den ordinære generalforsamling i Pharma Equity Group A/S...
Notice convening the annual general meeting in Pharma Equity Group A/S
March 25, 2024 08:06 ET
|
Pharma Equity Group A/S
25 March 2024 Announcement no. 10 Notice convening the annual general meeting in Pharma Equity Group A/S The board of directors hereby convenes the annual general meeting in Pharma...
Pharma Equity Group A/S (PEG) indgår aftale med Danske Bank om udøvelse af prisstillelse (Market Maker) i PEG aktien, fondskode: DK0061155009
March 22, 2024 04:00 ET
|
Pharma Equity Group A/S
Dato: 22. marts 2024 Årets meddelelse nr. 09 Pharma Equity Group A/S (PEG) indgår aftale med Danske Bank om udøvelse af prisstillelse (Market Maker) i PEG aktien, fondskode: DK0061155009 Pharma...
Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009
March 22, 2024 04:00 ET
|
Pharma Equity Group A/S
Date: 22 March 2024 Announcement of the Year No. 9 Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009 ...
Tegning af konvertible lån fuldført
March 21, 2024 11:33 ET
|
Pharma Equity Group A/S
Tegning af konvertible lån fuldført 21. marts 2024Meddelelse nr. 08 Bestyrelsen i Pharma Equity Group besluttede den 7. februar 2024 at udstede konvertible lån i overensstemmelse med...
Completion of subscription of convertible loans
March 21, 2024 11:33 ET
|
Pharma Equity Group A/S
Completion of subscription of convertible loans March 21, 2024Company Announcement no. 08 On 7 February 2024, the Board of Directors of Pharma Equity Group decided to issue...
Correction: Pharma Equity Group A/S - Årsrapport 2023
March 20, 2024 12:15 ET
|
Pharma Equity Group A/S
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Årsrapport 2023 Dato: 20. marts 2024 Årets meddelelse nr.: 07 Pharma Equity Group A/S - Årsrapport...
Correction: Pharma Equity Group A/S - Annual Report 2023
March 20, 2024 12:15 ET
|
Pharma Equity Group A/S
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual...